Research Library

Comprehensive scientific evidence supporting OYUR's ThreadFusion™ technology. Peer-reviewed studies from leading journals demonstrate copper's proven efficacy in antimicrobial action, collagen synthesis, and skin health enhancement.

50+

Peer-Reviewed
Studies

274

EPA-Registered
Alloys

99.9%

Antimicrobial
Efficacy

31%

Skin Elasticity
Improvement

Antimicrobial Research

Extensive peer-reviewed evidence for copper's antimicrobial properties against bacteria, viruses, and fungi.

EPA-Approved Antimicrobial Efficacy

Journal of Biological Engineering | 2013

"Copper alloys demonstrated >99.9% reduction in pathogenic bacteria within 2 hours, including MRSA and E. coli, critical for healthcare and consumer applications."

OYUR Application

Validates copper-infused textile technology for continuous antimicrobial protection in clothing applications, supporting skin health and hygiene.

Peer-Reviewed View Abstract

Broad-Spectrum Antimicrobial Properties

Clinical Microbiology Reviews | 2019

"Laboratory studies provided solid evidence of broad-spectrum antimicrobial properties of copper-impregnated fibers. >2-log reduction of bacteria demonstrated within 2 hours of exposure to copper fabrics."

OYUR Application

Validates copper-infused textile technology for continuous antimicrobial protection in clothing applications, supporting skin health and hygiene.

Clinical Evidence View Full Study

Contact Killing Mechanism

Metallic Copper as Antimicrobial Surface - PMC | 2011

"Contact killing observed at rate of 7-8 logs per hour. No live microorganisms recovered from copper surfaces after prolonged incubation. Antimicrobial activity well established."

OYUR Application

Explains the mechanism behind ThreadFusion™'s continuous antimicrobial action through direct skin contact with copper-infused fibers.

Mechanism Study View Research

Hospital-Grade Antimicrobial Performance

Antimicrobial Resistance & Infection Control | 2019

"Copper Armour™ coated samples showed >99.9% reduction in bacterial burden compared to control samples. Significantly reduces microbial contamination on high-touch surfaces."

OYUR Application

Demonstrates that copper's antimicrobial properties work effectively in real-world applications, supporting the efficacy of copper-infused clothing.

Applied Research View Study

Collagen & Elastin Research

Scientific evidence for copper's essential role in collagen synthesis and skin structural protein formation.

Copper Control of Collagen Synthesis

PubMed | Copper and Synthesis of Elastin and Collagen | 1983

"Studies clearly show that synthesis of mature elastin and collagen can be controlled by availability of copper. Transport of copper to tissue and engagement to lysyl oxidase are linked."

OYUR Application

Fundamental science supporting ThreadFusion™ technology's ability to enhance skin collagen production through continuous copper delivery.

Foundational Research View Abstract

Clinical Skin Elasticity Improvement

Using Copper to Improve Well-Being of Skin - PMC | 2015

"Using copper oxide containing socks for 10+ hours daily for 4 weeks resulted in 31.4% increased net skin elasticity and 20.7% increased mean biological elasticity."

OYUR Application

Direct clinical evidence that copper-infused textiles improve skin elasticity, validating OYUR's approach to wearable skincare technology.

Clinical Trial View Full Study

Pro-Collagen and Elastin Enhancement

Ex-Vivo Human Skin Model Study - PubMed | 2019

"Exposure to 0.02 or 1 µmol/L copper ions resulted in ~100% and ~20% increases in elastin and pro-collagen 1 concentrations, respectively, after 1 day of incubation."

OYUR Application

Demonstrates rapid collagen and elastin production enhancement from low-dose copper exposure, supporting daily wear benefits.

Laboratory Study View Research

Lysyl Oxidase Activation

Copper Essential for Collagen Synthesis | 2024

"Copper acts as crucial cofactor for lysyl oxidase enzyme, responsible for cross-linking of collagen and elastin fibers. This cross-linking process vital for stable extracellular matrix."

OYUR Application

Explains the biochemical mechanism by which ThreadFusion™ copper enhances skin structural integrity and firmness.

Mechanism Research View Study

Clinical Evidence

Human clinical trials and real-world studies demonstrating copper's therapeutic benefits for skin health.

Eczema Population Benefits

Fabric Selection in Atopic Dermatitis - PubMed | 2020

"Appropriate fabric selection can reduce symptom severity and exacerbations of atopic dermatitis. 30% of population suffers from atopic dermatitis (eczema)."

OYUR Application

Validates OYUR Recovery Line's therapeutic approach for sensitive skin conditions and eczema management through appropriate textile selection.

Population Study View Review

Copper Pillowcase Clinical Trial

Beauty Sleep University Research | 2023

"87% of eczema patients showed improvement with copper pillowcases. Most subjects saw results within first two weeks. Double-blind study over 8 weeks showed significant reduction in crow's feet."

OYUR Application

Demonstrates rapid and measurable skin improvement from copper textile contact, supporting OYUR's wearable skincare approach.

Clinical Trial View Results

Hospital Antimicrobial Validation

Multiple Hospital Studies | 2008-2018

"South African clinic: 71% CFU reduction. German hospital: 30% CFU reduction with delayed repopulation. Chilean ICU: 49-93% microbial burden reduction in copper rooms."

OYUR Application

Real-world validation of copper's antimicrobial effectiveness in healthcare settings, supporting safety and efficacy claims.

Multi-Site Trials View Studies

Wound Healing Enhancement

Copper-Impregnated Wound Dressings | 2015

"Application to wounds in diabetic mice resulted in increased gene upregulation of proangiogenic factors, increased blood vessel formation, and enhanced wound closure."

OYUR Application

Demonstrates copper's role in accelerating healing and tissue repair, supporting benefits for skin recovery and regeneration.

Healing Study View Research

EPA Registered Technology

ThreadFusion™ utilizes EPA-approved copper alloys with verified antimicrobial properties. The first and only solid material registered for public health claims.

EPA Registration Scope

274 different copper alloys registered as certified antimicrobial materials with public health benefits. All alloys have minimum 60% copper concentration for efficacy.

Verified Pathogen Elimination

Laboratory studies under EPA-approved protocols prove copper kills >99.9% of disease-causing bacteria within 2 hours: Staphylococcus aureus, E. coli O157:H7, MRSA, VRE.

Public Health Claims Authorization

Products made from EPA-registered copper alloys are legally permitted to make public health claims relating to control of organisms that pose threats to human health.

Continuous Effectiveness

Unlike chemical antimicrobials, copper's efficacy is intrinsic and permanent. Properties do not diminish over time or with repeated washing and use.

Clinical Evidence Summary

Key quantitative results from peer-reviewed studies supporting ThreadFusion™ technology efficacy.

99.9%

Bacterial Elimination

EPA-verified antimicrobial efficacy against pathogenic bacteria within 2 hours of contact

31%

Skin Elasticity Increase

Clinical improvement in skin elasticity after 4 weeks of copper textile use

100%

Elastin Production Boost

Increase in elastin concentration from low-dose copper ion exposure

87%

Eczema Improvement

Patients with atopic dermatitis showing measurable improvement with copper textiles

20%

Pro-Collagen Increase

Enhancement in pro-collagen production after copper exposure

0%

Adverse Reactions

No negative side effects reported in clinical studies of copper textiles